1. Ayers D (2013) Long non-coding RNAs: novel emergent biomarkers for cancer diagnostics. J Cancer Res Treat 1(2):31–35
2. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95
3. Centers for Medicare & Medicaid Services (2015).
https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/index.html?redirect=/clia
. Accessed 31 Jan 2015
4. Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE (2012) Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther 92(4):467–475
5. Cristofanilli M, Budd TG, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791